JNS-cover.jpgJournal of Neurological Sciences

Vol 483 | 15 April 2026

Editorial Board

Published in issue: April 15, 2026, 125861

Review Articles

The immune awakening: Transformative strategies against brain tumors

Ayesha Abdullah, Tayyaba Malik, Hafsa Shuja, ... Umer Wamiq, Hamza Yousuf Ibrahim, Muhammad Shafay Aamir

Basic Research Papers

Association of symptoms of neuropsychological long COVID with imaging and plasma biomarkers

Taizen Nakase, Yumi Takano, Shuko Nomura, ... Tadashi Ishii, Yasuko Tatewaki, Yasuyuki Taki


Profiling mitochondrial DNA indices across whole blood, plasma, and CSF in amyotrophic lateral sclerosis

Jiongming Bai, Xinyuan Pang, Hongfen Wang, ... Yifan Li, Mao Li, Xusheng Huang


Association of biological age markers with stroke prevalence: Insights from a cross-sectional study

Xiao Zhang, Zixuan Xing, Yaohui Jiang, ... Adam A. Dmytriw, Liqun Jiao, Tao Wang


Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in Italy

Stefania Corti, Giulio Gadaleta, Ilaria Bitetti, ... Marika Pane, Valeria A. Sansone the participants in the 2025 SMAkers workshop


Climate change and brain health, a risk management approach focusing on the European region: A narrative review

Jacques Reis, Alain Buguet, Zeliha Tulek, ... Emmeline Lagrange, Peter S. Spencer on behalf of the ENSG of the WFN


Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features

Antonio Ianniello, Elena Barbuti, Maria Francesca Capobianco, ... Carlo Pozzilli, Renato Cuocolo, Maria Petracca

Clinical Short Communications

Cerebrospinal fluid HOMER1 and NPTX2 as candidate signatures in early-stage multiple system atrophy-parkinsonism

Saki Hatakeyama, Yasuo Miki, Makoto Timon Tanaka, ... Masahiko Tomiyama, Akiyoshi Kakita, Koichi Wakabayashi

Letters to the Editor

Clinical implications of progressive ventilatory impairment in multiple system atrophy and progressive supranuclear palsy

Zen Kobayashi


Response to letter to the editor "Comment on: Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2/3 randomized controlled study"

Ryuji Kaji, Takayuki Ishida, Yuishin Izumi


Reply to the Letter to the Editor regarding "Clinical implications of progressive ventilatory impairment in multiple system atrophy and progressive supranuclear palsy"

So Okubo, Kenta Orimo, Jun Mitsui


Ultra-high-dose methylcobalamin demonstrates safety in advanced ALS, but intramuscular administration poses practical burdens and its selected study cohort limits generalizability

Mingxia Zhang, Yujie Zhang, Yuting Pu, Xue Bai


Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al.

Aman Ullah, Muhammad Mustafa Khan, Abdullah Abdullah, Asiya Shahzad


Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al

Shungo Imai, Keiko Ihara, Nobuyuki Takahashi, ... Jin Nakahara, Satoko Hori, Tsubasa Takizawa


Response to the letter by Yang and Xia: Clarifying the clinical and methodological boundaries of plasma and salivary p-Tau181 in Alzheimer's disease

Lucas Tadeu Rocha Santos, João Macedo Coelho Filho, Rômulo Rebouças Lôbo, Arnaldo Aires Peixoto Junior, Danielle S. Macedo


Letter to the editor: Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network

Fenglei Qian, Xiaomei Yao


Clarifying the clinical and methodological boundaries of plasma and salivary p-Tau181 in Alzheimer's disease

Mingyao Yang, Qin Xia


Distinguishing pharmacological toxicity from disease severity and lifestyle confounders in myasthenia gravis comorbidity models

Linru Zhong


Authors' response to reviewers' comments on "Effectiveness and safety of prasugrel- versus clopidogrel-based dual antiplatelet therapy for acute ischemic stroke"

Saki Nakashima, Shotaro Aso, Hideo Yasunaga, ... Kiyohide Fushimi, Tatsushi Toda, Satoshi Kodama


Letter to the editor: Effectiveness and safety of prasugrel- versus clopidogrel-based dual antiplatelet therapy for acute ischemic stroke

Qianyue Chen, Xianming Lin


Long term safety and efficacy of vigabatrin in Lennox-Gastuat syndrome: a long way to go

Jayantee Kalita, Firoz M. Nizami


Comment on "Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut syndrome (LennoVig): A single center randomized double-blind placebo-controlled trial"

Dileep Kumar Awasthi, Vikas Gupta, Subnesh Kumar Jain


Author response to letter

Fiorella S. Guido, John J. Chen, Paul A. Decker, ... Claudia F. Lucchinetti, Jeanette E. Eckel-Passow, W. Oliver Tobin


Letter to the editor: The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of Tumefactive demyelination

C.S. Chaitra, Shaun Nevil, S. Anton Charles, Jaladhi Madhusudhan


Commentary on "Impact of early cognitive and psychological status on return to work after acute ischemic stroke"

Huifen Ma


Response to commentary on "Impact of early cognitive and psychological status on return to work after acute ischemic stroke"

Yong Yi Tan, Gabriel Yi Ren Kwok, Benjamin Y.Q. Tan


Comment on "Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis"

Deeparani Urolagin, M.V. Kavyashree, B.A. Sowmya